The partial government shutdown, now the longest in U.S. history, began to take a bite out of biotech this week, served with a hot side dish of confusion.
Fort Worth, TX—Data analytics and visual search technologies are increasingly being used by law enforcement agencies, growth that has captured the attention of tech giant Motorola.
The Chicago-based tech company, which has long sold narrow-band radios to law enforcement, has... Read more »
Billions of dollars have already flowed to the purveyors of shared workspaces, and the investment spigot isn’t turning off yet.
Many of our devices, from wearables to medical instruments to drones, can capture reams of images. Using algorithms to analyze those images on the devices, in turn, generally takes loads of computing power and energy—sometimes more than is feasible.
AlwaysAI says... Read more »
Teradata on Monday announced that Oliver Ratzesberger, its chief operating officer, has been tapped as president and CEO Victor Lund’s successor.
The company, which last year relocated its headquarters from Dayton, OH, to San Diego, is in the midst... Read more »
The partial government shutdown may have diminished staffing at the SEC, but it hasn’t dimmed the hopes of biotech firms hoping to go public. On Friday, Kaleido Biosciences and Cirius Therapeutics both filed paperwork for their respective initial public offerings with... Read more »
The changing of the guard transforming retail is accelerating.
Sears, the nation’s first “everything store,” is teetering toward bankruptcy after years of stagnation as industry leaders prepare to gather in New York at the National Retail Federation’s annual conference. Yet, new... Read more »
As federal agency employees miss their first paychecks today due to the partial government shutdown that began Dec. 22, federal contractors and their workers—including technology professionals—face a loss of income that they may never recover.
Big technology companies such as Oracle... Read more »
From the cloud on down to the floors of supermarkets, the rivalry between Microsoft and Amazon spans many sectors in software, gadgets, and increasingly, retail.
The Seattle-area tech giants are battling—both with one another, and other competitors—to further digitize grocery shopping.... Read more »
The flow of biotech news is particularly heavy today, and for good reason. The annual J.P. Morgan Healthcare Conference, one of the biggest gatherings for the biopharmaceutical industry, kicked off today in San Francisco, and many companies, whether they’re speaking at... Read more »
Looking back over the past two years, it seems that public perceptions of tech companies have shifted, compared with the eager acceptance that often prevailed as innovations from these businesses transformed social interactions, transportation, and other aspects of life.
In early... Read more »
Poseida Therapeutics, which is testing CAR-T cell therapies for blood-borne and solid tumor cancers, has laid the groundwork for an initial public offering.
In 2018, my Exome colleagues and I published hundreds of stories about health, medicine, the biopharma industry, government policy, and more. You’ll find a few of our favorite stories in this review of some of the year’s best from across the... Read more »
When it comes to developing and promoting innovation, external factors beyond the control of company founders, investors, and other business leaders can also determine whether a startup succeeds or fails.
In 2018, geopolitical events—in particular, President Donald Trump’s hard-line stances on... Read more »
[Updated 1/4/19, 9:10 p.m. PT. See below.] As strains of bacteria evolve to fight back against common antibiotics, a slew of biotechnology companies are working to develop ways to combat these “superbugs.”
San Diego’s Forge Therapeutics is among those targeting gram-negative... Read more »
Professor, Gene Expression Laboratory, Salk Institute
President and CEO, Biocom
Director, UCSD Division of the California Institute for Telecommunications and Information Technology
Founding Director of Calit2
Founder and CEO, Noble Environmental Technologies
Senior Fellow, Kauffman Foundation
Co-founder and Managing Partner, TVC Capital
Founder and CEO, Isis Pharmaceuticals
Former President and CEO, Regulus Therapeutics
Dean, University of San Diego School of Law